Knowledge bank grows as genome sequencing becomes mainstream

02/19/2013 | New York Times (tiered subscription model), The

As the price of sequencing the human genome has fallen, parents of children with undiagnosed or rare diseases have become more willing to have their children's genomes sequenced, thus adding to the available data on genetic mutations. Expectations are high, but the technology leads to beneficial treatment in only about 1% of patients.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ